results indicated that the effective dose of acyclovir ( acv ) required to inhibit hsv-2-transformed and tumor-derived cell growth by 50 % ( ed50 ) compared to mock-treated control cells averaged 15 to 75 micrograms/ml .
C0007595
cell growth
C0007634
cells